Aristotle University Of Thessaloniki (AUTH)
Επίδραση των μεσεγχυματικών πολυδύναμων κυττάρων και της βινποσετίνης σε in vitro μοντέλο ηλικιακής εκφύλισης της ωχράς κηλίδας
Abstract
dc:descriptionAge-related macular degeneration (AMD) is the leading cause of vision loss in the developed world, with no effective treatment available to date. The aim of the present study is to evaluate the effects of bone marrow stem cells (BMSCs), vinpocetine and their combination in an amyloid-β (Aβ)-induced in vitro model of AMD. Materials and Methods: Human retinal pigment epithelial cells (ARPE-19) were utilized and exposed to 10 μM Aβ1–42 for 24 hours. Cells were allocated into the following groups: (i) BMSC co-culture, (ii) vinpocetine treatment, (iii) combined BMSCs and vinpocetine treatment, (iv) Aβ1–42 exposure alone, and (v) control group. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) and MTT assays. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine mRNA expression levels of genes associated with angiogenesis—vascular endothelial growth factor A (VEGF-A) and pigment epithelium-derived factor (PEDF)—and with the visual cycle, including: lecithin–retinol acyltransferase (LRAT), retinoid isomerohydrolase (RPE65), retinol dehydrogenase 5 (RDH5), retinol dehydrogenase 10 (RDH10), and retinaldehyde-binding protein 1 (RLBP1). Furthermore, enzyme-linked immunosorbent assay (ELISA) was employed to quantify protein levels of the inflammatory cytokines interleukin (IL)-6 and IL-8, as well as MerTK expression, reflecting the phagocytic function of the retinal pigment epithelium (RPE). Results: Exposure to 10 μM Aβ1–42 resulted in a significant reduction in ARPE-19 cell viability (p = 0.02), whereas all proposed interventions significantly restored viability to near-control levels. Aβ1–42 exposure induced an increase in VEGF-A expression, which was significantly reduced in all intervention groups. Concurrently, Aβ1–42 caused a mild increase in PEDF expression; however, a significant upregulation was observed in the intervention groups, with the combined BMSC and vinpocetine treatment demonstrating the strongest effect (p = 0.02). Furthermore, Aβ1–42 exposure led to increased expression of most visual cycle–related genes, which was restored by the interventions. In addition, Aβ1–42 significantly elevated protein levels of the inflammatory cytokines IL-6 and IL-8, whereas their levels were significantly reduced in all treatment groups. MerTK levels were significantly increased in response to Aβ1–42 exposure, possibly reflecting a compensatory clearance mechanism of the retinal pigment epithelium. Conclusions: In summary, the present study demonstrates that Aβ1–42 plays a pivotal role in inducing cytotoxicity, promoting angiogenesis, activating inflammatory responses, and disrupting the expression of visual cycle–related genes in RPE. These alterations represent key pathogenic mechanisms contributing to the progression of AMD. Intervention with BMSCs, vinpocetine, and their combination, significantly reversed these effects and contributed to the restoration of epithelial structural and functional integrity. These findings highlight the potential therapeutic value of the proposed approaches in AMD. Further investigation in other preclinical and clinical models is warranted.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Almpanidou, Stavroula
- Αλμπανίδου, Σταυρούλα
Subjects
dc:subject × 18- Ηλικιακή εκφύλιση της ωχράς κηλίδας
- Βλαστοκύτταρα μυελού των οστών
- Βινποσετίνη
- Μελάγχρουν επιθήλιο
- Age-related macular degeneration
- Bone marrow stem cells
- Vinpocetine
- Retinal pigment epithelium
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Οφθαλμολογία
- Βασική Ιατρική
- Αισθητήρια συστήματα
- Clinical Medicine
- Medical and Health Sciences
- Ophthalmology
- Basic Medicine
- Sensory Systems
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60903